Utah Medical Products (UTMD) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $84.3 million.
- Utah Medical Products' Cash & Equivalents fell 473.14% to $84.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year decrease of 473.14%. This contributed to the annual value of $83.0 million for FY2024, which is 1065.17% down from last year.
- Latest data reveals that Utah Medical Products reported Cash & Equivalents of $84.3 million as of Q3 2025, which was down 473.14% from $82.2 million recorded in Q2 2025.
- Over the past 5 years, Utah Medical Products' Cash & Equivalents peaked at $93.8 million during Q1 2024, and registered a low of $56.0 million during Q1 2021.
- In the last 5 years, Utah Medical Products' Cash & Equivalents had a median value of $82.2 million in 2025 and averaged $77.3 million.
- In the last 5 years, Utah Medical Products' Cash & Equivalents skyrocketed by 4145.1% in 2021 and then plummeted by 1117.5% in 2025.
- Quarter analysis of 5 years shows Utah Medical Products' Cash & Equivalents stood at $61.0 million in 2021, then rose by 23.09% to $75.1 million in 2022, then rose by 23.74% to $92.9 million in 2023, then dropped by 10.65% to $83.0 million in 2024, then grew by 1.56% to $84.3 million in 2025.
- Its last three reported values are $84.3 million in Q3 2025, $82.2 million for Q2 2025, and $83.3 million during Q1 2025.